Histiocytoid Sweet Syndrome: A Distinct Entity Within the Spectrum of Myeloid Dermatoses
Journal of Cutaneous Pathology · 05.11.2026
DOI: 10.1111/cup.70233 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cutaneous Pathology, online erschienen am 05.11.2026. Verfasst von Ava Scott und 1 weiteren Autor:innen. Beteiligte Einrichtung: Saint Louis University School of Medicine, St. Louis, Missouri, USA. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Histiocytoid Sweet syndrome (H‐SS) is a variant of Sweet syndrome characterized by a dermal infiltrate of immature myeloid cells with histiocytoid morphology rather than mature neutrophils. These cells express myeloid markers including myeloperoxidase, lysozyme, CD15, and CD13. H‐SS has been associated with hematologic malignancies and demonstrates higher relapse rates compared with classic Sweet syndrome. This review synthesizes current evidence on the clinicopathologic features, immunophenotype, disease associations, and treatment of H‐SS, and examines its position within the broader spectrum of myeloid cutaneous infiltrates.
Autor:innen und Institutionen
- Saint Louis University School of Medicine, St. Louis, Missouri, USA.
- Department of Dermatology, SSM Health/Saint Louis University, St. Louis, Missouri, USA.
ORCID-Profile: Ava Scott, Emily Smith
Zitieren
APA
Scott, A., & Smith, E. (2026). Histiocytoid Sweet Syndrome: A Distinct Entity Within the Spectrum of Myeloid Dermatoses. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.70233
Vancouver
Scott A, Smith E. Histiocytoid Sweet Syndrome: A Distinct Entity Within the Spectrum of Myeloid Dermatoses. Journal of Cutaneous Pathology. 2026. doi:10.1111/cup.70233
BibTeX
@article{Scott2026,
author = {Scott, Ava and Smith, Emily},
title = {Histiocytoid Sweet Syndrome: A Distinct Entity Within the Spectrum of Myeloid Dermatoses},
journal = {Journal of Cutaneous Pathology},
year = {2026},
doi = {10.1111/cup.70233}
}
EUVIMED